Study record

MOTS-c as a predictor of coronary lesions and complexity in patients with stable coronary artery disease

Yaşar E, Çakmak T, Bayramoğlu A et al. · Eur Rev Med Pharmacol Sci · 2022

Human obs.Endogenous MOTS-c measuredEvidence tier B

What this study reported

Measured circulating MOTS-c in patients with stable angina and reported lower levels in those with angiographically confirmed coronary artery disease than in those with normal coronary arteries. Reported that MOTS-c was an independent predictor of coronary artery disease in multiple regression analysis and described a receiver operating characteristic threshold with 80.3% sensitivity and 73.2% specificity in this sample.

Limitations

Cross-sectional single-centre design that cannot establish temporal order; measurement units for MOTS-c are not stated and the reported confidence interval is inconsistent with the reported area under the curve; diagnostic threshold derived and tested in the same sample without validation.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedEndogenous MOTS-c measuredNaturally occurring MOTS-c was measured; nothing was given.
Specieshuman
System studiedPatients with stable angina undergoing coronary angiography, with and without angiographic coronary artery disease
PopulationAdults with stable angina pectoris, with stable coronary artery disease or normal coronary arteries
DesignCase-control study with angiographic severity scoring
Sample size as reported184 patients (92 with coronary artery disease, 92 with normal coronary arteries)
Control group92 consecutive patients with normal coronary arteries
Route (data field only)Not reported
Endpoints measuredcirculating MOTS-c levels; presence of coronary artery disease; SYNTAX score
Pathways measuredNot reported
Research areasCardiovascular
Evidence tierB — Other human study
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Small
Controls
Appropriate
Outcome validity
Exploratory
Support for its own conclusion
Weak

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.